My Legacy Advisors, LLC Gilead Sciences, Inc. Transaction History

My Legacy Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	BUY	$73.27 - $83.09 $18,610 - $21,104	254 Added 1.7%	15,210 $1.23 Million
Q3 2023 Oct 20, 2023	BUY	$73.94 - $80.67 $20,555 - $22,426	278 Added 1.89%	14,956 $1.12 Million
Q2 2023 Jul 14, 2023	SELL	$76.01 - $86.7 $22,346 - $25,489	-294 Reduced 1.96%	14,678 $1.13 Million
Q1 2023 Apr 11, 2023	BUY	$77.31 - $88.08 $27,831 - $31,708	360 Added 2.46%	14,972 $1.24 Million
Q4 2022 Feb 07, 2023	BUY	$62.32 - $89.47 $77,900 - $111,837	1,250 Added 9.35%	14,612 $1.25 Million
Q3 2022 Oct 17, 2022	BUY	$59.54 - $68.01 $304,130 - $347,395	5,108 Added 61.89%	13,362 $884,000
Q2 2022 Jul 12, 2022	BUY	$57.72 - $65.01 $476,420 - $536,592	8,254 New	8,254 $517,000

1,880

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of My Legacy Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on My Legacy Advisors, LLC with notifications on news.